A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy

PURPOSE: We report the toxicity and biochemical tumor control outcome of a prospective Phase II study using high-dose-rate brachytherapy (HDR) alone as a salvage therapy for recurrent disease after external beam radiotherapy (EBRT). METHODS: Forty-two patients with biopsy-proven recurrence were enro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yoshiya, Kollmeier, Marisa A., Pei, Xin, Kan, Chu Cheng, Cohen, Gil’ad N., Donat, Sherri M., Cox, Brett W., Zelefsky, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718052/
https://www.ncbi.nlm.nih.gov/pubmed/24373762
http://dx.doi.org/10.1016/j.brachy.2013.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718052/
https://www.ncbi.nlm.nih.gov/pubmed/24373762
http://dx.doi.org/10.1016/j.brachy.2013.11.005

Ejemplares similares